181. In persons exposed to influenza, zanamivir, oseltamivir, laninamivir, and baloxavir reduce symptomatic seasonal influenza.
Zhao Y, Gao Y, Guyatt G, et al. Antivirals for post-exposure prophylaxis of influenza: a systematic review and network meta-analysis. Lancet. 2024;404:764-772. 39181596.
182. In hospitalized patients with influenza, oseltamivir or peramivir may reduce hospital length of stay (low-certainty evidence).
Gao Y, Guyatt G, Uyeki TM, et al. Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials. Lancet. 2024;404:753-763. 39181595.
183. Adding naloxone to buprenorphine during pregnancy was not linked to increased adverse neonatal or maternal outcomes.
Straub L, Bateman BT, Hernández-Díaz S, et al. Comparative safety of in utero exposure to buprenorphine combined with naloxone vs buprenorphine alone. JAMA. 2024;332:805-816. 39133511.
184. The Past, Present, and Future of Restrictive Covenants in Medicine in the United States : A Narrative Review.
Restrictive covenants (RCs) are clauses placed into employment agreements across various industries, and they are frequently used in health care-specifically within physician contracts. Given the most recent guidance and rule determined by the Federal Trade Commission in April 2024, the relevancy of RCs in health care has come under even more scrutiny in the latter half of 2024. This review will focus on the history of RC law and review the value of these clauses from the perspectives of the employer, practicing physician, and patient. We also provide the stakeholder responses to both the ban and the subsequent blockage of enforcement by a Texas federal court in August of 2024.
185. In acute ischemic stroke and a large infarct, adding EVT to medical treatment improved functional outcome at 12 mo.
Thomalla G, Fiehler J, Subtil F, et al; TENSION Investigators. Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial. Lancet Neurol. 2024;23:883-892. 39074480.
186. A Framework for Considering the Value of Race and Ethnicity in Estimating Disease Risk.
作者: Madison Coots.;Soroush Saghafian.;David M Kent.;Sharad Goel.
来源: Ann Intern Med. 2025年178卷1期98-107页
Accounting for race and ethnicity in estimating disease risk may improve the accuracy of predictions but may also encourage a racialized view of medicine.
187. After COVID-19 diagnosis, risk for incident type 2 diabetes was elevated for up to 2 y.
Taylor K, Eastwood S, Walker V, et al. Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people. Lancet Diabetes Endocrinol. 2024;12:558-568. 39054034.
188. Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.
作者: Jean-François Laprise.;Harrell W Chesson.;Lauri E Markowitz.;Mélanie Drolet.;Marc Brisson.
来源: Ann Intern Med. 2025年178卷1期50-58页
In June 2019, the U.S. Advisory Committee on Immunization Practices recommended shared clinical decision making regarding potential human papillomavirus (HPV) vaccination of men and women aged 27 to 45 years ("mid-adults").
189. Association of Work Control With Burnout and Career Intentions Among U.S. Physicians : A Multi-institution Study.
作者: Christine A Sinsky.;Roger L Brown.;Lisa Rotenstein.;Lindsey E Carlasare.;Purva Shah.;Tait D Shanafelt.
来源: Ann Intern Med. 2025年178卷1期20-28页
Physician control over their clinical work is hypothesized to be associated with both burnout and career intentions.
190. The Effect of Denosumab on Risk for Emergently Treated Hypocalcemia by Stage of Chronic Kidney Disease : A Target Trial Emulation.
作者: Steven T Bird.;Kate Gelperin.;Elizabeth R Smith.;Tae Hyun Jung.;Hai Lyu.;Aliza Thompson.;Olivia Easley.;Kushal B Naik.;Yueqin Zhao.;Rekha Kambhampati.;Michael Wernecke.;Ali Niak.;Marina Zemskova.;Yoganand Chillarige.;Jeffrey A Kelman.;David J Graham.
来源: Ann Intern Med. 2025年178卷1期29-38页
There is a paucity of data on treatment of osteoporosis in patients with advanced chronic kidney disease (CKD).
191. Information Disclosure, Medical Device Regulation, and Device Safety: The Case of Cook Celect IVC Filters.
作者: Kushal T Kadakia.;Behnood Bikdeli.;Aakriti Gupta.;Sanket S Dhruva.;Joseph S Ross.;Harlan M Krumholz.
来源: Ann Intern Med. 2024年177卷12期1711-1718页
Although medical devices are widely used in clinical practice, clinicians and the public have limited access to information on how devices are tested, regulated, and used, posing challenges to patient safety. This article uses Cook Medical's Celect inferior vena cava (IVC) filter, a medical device used for prevention of pulmonary embolism, as a case study of the transparency gap in medical device regulation. Recently unsealed court documents from litigation related to Celect reveal that the device's clinical study protocol did not follow U.S. Food and Drug Administration (FDA) guidance for IVC filter testing and that study outcome definitions for IVC perforation had lower sensitivity for detecting adverse events than those recommended by professional societies. Furthermore, a comparison of court documents and the public record indicates that adverse events and patient deaths were misreported to FDA reviewers and were inaccurately reported in the published literature and on the device label, providing patients and clinicians with inaccurate information about the device's safety. The Celect IVC filter case demonstrates the need for regulatory reforms to ensure that critical safety data are accessible to the FDA, clinicians, and patients to inform decision making.
192. Artificial Intelligence-Assisted Colonoscopy for Polyp Detection : A Systematic Review and Meta-analysis.
作者: Saeed Soleymanjahi.;Jack Huebner.;Lina Elmansy.;Niroop Rajashekar.;Nando Lüdtke.;Rumzah Paracha.;Rachel Thompson.;Alyssa A Grimshaw.;Farid Foroutan.;Shahnaz Sultan.;Dennis L Shung.
来源: Ann Intern Med. 2024年177卷12期1652-1663页
Randomized clinical trials (RCTs) of computer-aided detection (CADe) system-enhanced colonoscopy compared with conventional colonoscopy suggest increased adenoma detection rate (ADR) and decreased adenoma miss rate (AMR), but the effect on detection of advanced colorectal neoplasia (ACN) is unclear.
193. Colorectal Cancer Screening Completion and Yield in Patients Aged 45 to 50 Years : An Observational Study.
作者: Theodore R Levin.;Christopher D Jensen.;Natalia Udaltsova.;Andrea A Burnett-Hartman.;Aruna Kamineni.;Chun R Chao.;Joanne E Schottinger.;Nirupa R Ghai.;Gaia Pocobelli.;Larissa L White.;Malia Oliver.;Hina Chowdhry.;Brian P Hixon.;Jessica M Badalov.;Shauna R Goldberg.;Susan C Bradford.;Charles P Quesenberry.;Jeffrey K Lee.
来源: Ann Intern Med. 2024年177卷12期1621-1629页
Guidelines now recommend initiating colorectal cancer (CRC) screening at age 45 years rather than 50 years, but little is known about screening completion and yield among people aged 45 to 49 years.
194. The Effect of the "Safety in Dementia" Online Tool to Assist Decision Making for Caregivers of Persons With Dementia and Access to Firearms : A Randomized Trial.
作者: Marian E Betz.;Jennifer Portz.;Christopher Knoepke.;Megan L Ranney.;Stacy M Fischer.;Ryan A Peterson.;Rachel L Johnson.;Faris Omeragic.;Mirella Castaneda.;Emily Greenway.;Daniel Matlock.
来源: Ann Intern Med. 2024年177卷12期1630-1640页
Caregivers face challenges (including competing desires to prevent injury, respect autonomy, and avoid conflict) when addressing firearm access by community-dwelling persons with Alzheimer disease and related dementias (ADRD).
195. Clinical Tools to Assess Functional Capacity During Risk Assessment Before Elective Noncardiac Surgery : A Scoping Review.
作者: Julian F Daza.;Tyler R Chesney.;Juan F Morales.;Yuanxin Xue.;Sandra Lee.;Leandra A Amado.;Bianca Pivetta.;Arnaud R Mbadjeu Hondjeu.;Rachel Jolley.;Calvin Diep.;Shabbir M H Alibhai.;Peter M Smith.;Erin D Kennedy.;Elizabeth Racz.;Luke Wilmshurst.;Duminda N Wijeysundera.
来源: Ann Intern Med. 2025年178卷1期75-87页
Functional capacity is critical to preoperative risk assessment, yet guidance on its measurement in clinical practice remains lacking.
196. Dementia.
Dementia, or major neurocognitive disorder, is defined as a decline in 1 or more cognitive domains that causes impairment in everyday function. Alzheimer disease is the most common type of dementia in the United States, with an estimated 6.9 million adults who have Alzheimer disease and are 65 years or older. This article discusses the latest findings in preventing cognitive decline. It also discusses dementia screening, diagnosis, treatment, and the quality of life for persons with dementia and their caregivers.
197. Patients surviving COVID-19 had lower risk for long COVID in the Omicron vs. earlier eras.
Xie Y, Choi T, Al-Aly Z. Postacute sequelae of SARS-CoV-2 infection in the pre-Delta, Delta, and Omicron eras. N Engl J Med. 2024;391:515-525. 39018527.
198. Ensuring Safe Practice by Late Career Physicians: Institutional Policies and Implementation Experiences.
作者: Andrew A White.;Thomas H Gallagher.;Paulina H Osinska.;Daniel B Kramer.;Kelly Davis Garrett.;Michelle M Mello.
来源: Ann Intern Med. 2024年177卷12期1702-1710页
Late career physicians (LCPs; physicians working beyond age 65 to 75 years) may be at higher risk for delivering unsafe care. To oversee LCPs, some health care organizations (HCOs) have adopted LCP policies requiring cognitive, physical, and practice performance screening assessments. Despite recent controversies, little is known about the content and implementation of such policies.
199. In active ulcerative colitis, risankizumab induced and maintained remission.
Louis E, Schreiber S, Panaccione R, et al; INSPIRE and COMMAND Study Group. Risankizumab for ulcerative colitis: two randomized clinical trials. JAMA. 2024;332:881-897. 39037800.
200. In symptomatic knee OA, adding oral methotrexate to usual analgesia reduced pain at 6 mo.
Kingsbury SR, Tharmanathan P, Keding A, et al. Pain reduction with oral methotrexate in knee osteoarthritis: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2024;177:1145-1156. 39074374.
|